Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye
More testing and research need to be done to identify the relative prevalence of rare AATD variants. Earlier identification could lead to more effective treatment of affected individuals and improvement in their quality of life.
Authors
- Lourdes Osaba
- Nur Hürsoy (ORCID: https://orcid.org/0000-0001-5059-2268)
- Bettina Dreger
- Bilge Kara (ORCID: https://orcid.org/0000-0003-2690-4932)
- Ünal Şahin (ORCID: https://orcid.org/0000-0003-1836-6193)
- Songül Özyurt (ORCID: https://orcid.org/0000-0002-9768-1425)
- Tahsin Gökhan Telatar (ORCID: https://orcid.org/0000-0002-3261-3464)
- Dilek Karadoğan (ORCID: https://orcid.org/0000-0001-5321-3964)
- Enes Ahmetoğlu (ORCID: https://orcid.org/0000-0002-2628-2881)
Institutions
- Recep Tayyip Erdoğan University (TR)
- Grifols (Germany) (DE)
- Grifols (Spain) (ES)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s12890-024-03421-y
- Citations
- 2
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Grifols